Celldex Therapeutics Inc (CLDX) R&D Expenses & History | Stock Alarm

Demo Sign up Log In

Celldex Therapeutics Inc · R&D Expenses

CLDX R&D Expenses

Latest reported$278.84Mperiod endingJun 30, 2026

CLDX R&D Expenses ($0.00 → $278.84M)

Annual R&D Expenses

High-resolution chart · PNG

CLDX r&d expenses history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Celldex Therapeutics Inc R&D Expenses — Annual fiscal periods (USD)
Period ending	R&D Expenses (USD)
Dec 31, 2025	245,100,000
Dec 31, 2024	163,550,000
Dec 31, 2023	118,011,000
Dec 31, 2022	82,258,000
Dec 31, 2021	56,811,000
Dec 31, 2020	40,534,000
Dec 31, 2019	42,672,000
Dec 31, 2018	66,449,000
Dec 31, 2017	96,171,000
Dec 31, 2016	102,726,000
Dec 31, 2015	100,171,000
Dec 31, 2014	104,381,000
Dec 31, 2013	67,401,000
Dec 31, 2012	47,398,000
Dec 31, 2011	32,439,000
Dec 31, 2010	27,650,000
Dec 31, 2009	26,169,000
Dec 31, 2008	26,347,189
Dec 31, 2007	18,495,788
Dec 31, 2006	18,066,392
Dec 31, 2005	14,063,295
Dec 31, 2004	13,873,800
Dec 31, 2003	10,021,300
Dec 31, 2002	14,708,500
Dec 31, 2001	21,580,500
Dec 31, 2000	10,774,200
Dec 31, 1999	7,871,800
Dec 31, 1998	5,700,000
Dec 31, 1997	5,300,000
Dec 31, 1996	6,000,000
Dec 31, 1995	8,000,000
Dec 31, 1994	8,700,000
Dec 31, 1993	0
Dec 31, 1992	0
Apr 30, 1992	0
Apr 30, 1990	0
Apr 30, 1989	0
Apr 30, 1988	0
Apr 30, 1987	0
Apr 30, 1986	0

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.